DHI vs SRPT · P/E 9.6, rev $34.25B vs rev $1.13B
DR Horton Inc (DHI) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
DR Horton Inc (DHI) is a residential construction company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported DHI revenue for 2025-09-30 was $34.25B. Net income was $3.62B. DHI currently screens at market cap $39.10B and trailing P/E 9.6.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
DHI currently screens at market cap $39.10B and trailing P/E 9.6. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the DHI and SRPT stock pages for the full models.
Not investment advice.